Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.

by Lee Admoni-Elisha, Itay Nakdimon, Anna Shteinfer, Tal Prezma, Tasleem Arif, Nir Arbel, Anna Melkov, Ori Zelichov, Itai Levi, Varda Shoshan-Barmatz
Published 2016-01-01

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort

by Stephen R. Fairclough, Lesli A. Kiedrowski, Jessica J. Lin, Ori Zelichov, Gabi Tarcic, Thomas E. Stinchcombe, Justin I. Odegaard, Richard B. Lanman, Alice T. Shaw, Rebecca J. Nagy
Published 2019-10-01

Comparing genomic landscape of early stage, treatment naïve and late stage, drug resistant EGFR-mutant lung adenocarcinomas

by Rahul Nahar, Yin Yeng Lee, Alexis J. Khng, Tong Zhang, Angela Takano, Xingliang Liu, Jacob J.S. Alvarez, Ori Zelichov, Ezra Ella, Zohar Barbash, Chong Hee Lim, Tina P.T. Koh, Zaw Win Aung, Tony Kiat Hon Lim, Chee Keong Toh, Wan-Teck Lim, Bing Lim, Wai Leong Tam, Eng-Huat Tan, Weiwei Zhai, Daniel S.W. Tan, Axel M. Hillmer
Published 2017-12-01